Alla Danilkovitch insider trades: Osiris Therapeutics (OSIR) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Alla reports to the SEC
Open-market buys and sales
1 trade reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 10, 2015 | OSIR | ↓ Sell | 2,425 | $18.22 | $44K | Direct | Aug 11, 2015 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Alla Danilkovitch's insider trades
Alla Danilkovitch is Chief Scientific Officer at Osiris Therapeutics (OSIR). Since Aug 10, 2015, Alla has reported no open-market purchases and 1 sale worth $44K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include option exercises (2 filings), shares returned to the company (1 filing), grants and awards (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every OSIR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.